Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Spectrum Analysis, Raman | 19 | 2022 | 237 | 2.160 |
Why?
|
Silver | 11 | 2022 | 117 | 2.040 |
Why?
|
Nanoparticles | 14 | 2022 | 1953 | 1.720 |
Why?
|
Metal Nanoparticles | 9 | 2024 | 396 | 1.510 |
Why?
|
Fluorescent Dyes | 17 | 2023 | 1900 | 1.500 |
Why?
|
Silicon Dioxide | 15 | 2024 | 216 | 1.440 |
Why?
|
Iron Overload | 3 | 2022 | 239 | 0.930 |
Why?
|
Polyethylene Glycols | 5 | 2021 | 1189 | 0.910 |
Why?
|
Quantum Dots | 4 | 2022 | 167 | 0.850 |
Why?
|
Iron Chelating Agents | 2 | 2022 | 141 | 0.680 |
Why?
|
Nanostructures | 7 | 2019 | 552 | 0.660 |
Why?
|
Surgery, Computer-Assisted | 3 | 2022 | 1007 | 0.640 |
Why?
|
Kidney | 4 | 2019 | 7046 | 0.530 |
Why?
|
Receptor, erbB-2 | 3 | 2021 | 2553 | 0.470 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2019 | 616 | 0.450 |
Why?
|
Tissue Distribution | 6 | 2023 | 2265 | 0.400 |
Why?
|
Nanoshells | 3 | 2024 | 11 | 0.390 |
Why?
|
Gold | 5 | 2024 | 478 | 0.380 |
Why?
|
Deferoxamine | 2 | 2022 | 154 | 0.370 |
Why?
|
Antineoplastic Agents | 4 | 2023 | 13616 | 0.360 |
Why?
|
Spectroscopy, Near-Infrared | 5 | 2023 | 740 | 0.360 |
Why?
|
Neoplasms | 7 | 2023 | 22083 | 0.340 |
Why?
|
Antibodies | 1 | 2017 | 2421 | 0.330 |
Why?
|
Peptides | 3 | 2019 | 4338 | 0.320 |
Why?
|
Drug Delivery Systems | 6 | 2023 | 2224 | 0.310 |
Why?
|
Nanotechnology | 5 | 2015 | 712 | 0.300 |
Why?
|
Microspheres | 4 | 2012 | 787 | 0.290 |
Why?
|
Particle Size | 6 | 2019 | 1643 | 0.280 |
Why?
|
Colonic Neoplasms | 1 | 2017 | 2529 | 0.260 |
Why?
|
Lung Neoplasms | 5 | 2023 | 13312 | 0.240 |
Why?
|
Mice, Nude | 3 | 2022 | 3603 | 0.230 |
Why?
|
Mice | 19 | 2023 | 81402 | 0.210 |
Why?
|
Animals | 28 | 2023 | 168253 | 0.200 |
Why?
|
Nanocomposites | 1 | 2022 | 49 | 0.200 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 5296 | 0.200 |
Why?
|
Cyclobutanes | 1 | 2022 | 57 | 0.200 |
Why?
|
Cell Line, Tumor | 7 | 2021 | 16945 | 0.200 |
Why?
|
Molecular Probe Techniques | 2 | 2012 | 111 | 0.180 |
Why?
|
Anisoles | 1 | 2019 | 6 | 0.170 |
Why?
|
Contrast Media | 4 | 2023 | 5310 | 0.170 |
Why?
|
Coloring Agents | 2 | 2020 | 559 | 0.170 |
Why?
|
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2019 | 114 | 0.160 |
Why?
|
Macrophage Colony-Stimulating Factor | 1 | 2019 | 186 | 0.160 |
Why?
|
Ionophores | 3 | 2023 | 107 | 0.160 |
Why?
|
Half-Life | 1 | 2019 | 652 | 0.160 |
Why?
|
Magnetics | 3 | 2010 | 599 | 0.150 |
Why?
|
Molecular Weight | 1 | 2019 | 2188 | 0.140 |
Why?
|
Indocyanine Green | 1 | 2019 | 233 | 0.140 |
Why?
|
Nanomedicine | 1 | 2019 | 291 | 0.140 |
Why?
|
Phenols | 3 | 2022 | 517 | 0.140 |
Why?
|
Glutamate Carboxypeptidase II | 1 | 2017 | 81 | 0.140 |
Why?
|
beta-Cyclodextrins | 1 | 2016 | 70 | 0.130 |
Why?
|
Hydrogels | 1 | 2022 | 723 | 0.130 |
Why?
|
Proteins | 4 | 2014 | 6033 | 0.130 |
Why?
|
Fluorescent Antibody Technique | 2 | 2018 | 2468 | 0.130 |
Why?
|
Photochemotherapy | 1 | 2022 | 823 | 0.130 |
Why?
|
Peritoneal Neoplasms | 1 | 2022 | 711 | 0.130 |
Why?
|
Pharmacokinetics | 1 | 2015 | 86 | 0.130 |
Why?
|
Area Under Curve | 1 | 2019 | 1633 | 0.130 |
Why?
|
Volatile Organic Compounds | 1 | 2016 | 85 | 0.130 |
Why?
|
Ovarian Neoplasms | 2 | 2022 | 4879 | 0.120 |
Why?
|
Influenza A virus | 1 | 2018 | 457 | 0.120 |
Why?
|
Liposomes | 1 | 2019 | 781 | 0.120 |
Why?
|
Biosensing Techniques | 2 | 2011 | 649 | 0.120 |
Why?
|
Sulfhydryl Compounds | 2 | 2013 | 297 | 0.120 |
Why?
|
Nanotubes, Carbon | 1 | 2015 | 71 | 0.120 |
Why?
|
Graphite | 1 | 2015 | 77 | 0.120 |
Why?
|
Polymers | 2 | 2012 | 1615 | 0.120 |
Why?
|
Ferrosoferric Oxide | 1 | 2015 | 348 | 0.120 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2022 | 2498 | 0.120 |
Why?
|
Polystyrenes | 3 | 2009 | 104 | 0.120 |
Why?
|
Iodine Radioisotopes | 1 | 2017 | 1033 | 0.110 |
Why?
|
Peptide Library | 1 | 2015 | 347 | 0.110 |
Why?
|
Magnetite Nanoparticles | 1 | 2015 | 316 | 0.110 |
Why?
|
Antibodies, Neoplasm | 1 | 2015 | 281 | 0.110 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2019 | 3590 | 0.110 |
Why?
|
HeLa Cells | 1 | 2019 | 3097 | 0.110 |
Why?
|
Oxides | 1 | 2015 | 401 | 0.110 |
Why?
|
Asthma | 2 | 2023 | 6195 | 0.100 |
Why?
|
Antigens, Surface | 1 | 2017 | 1608 | 0.100 |
Why?
|
Antibodies, Bispecific | 1 | 2015 | 196 | 0.100 |
Why?
|
Surface Properties | 5 | 2015 | 1160 | 0.100 |
Why?
|
Tumor Microenvironment | 2 | 2022 | 3874 | 0.100 |
Why?
|
Pathology, Molecular | 1 | 2015 | 328 | 0.100 |
Why?
|
ROC Curve | 1 | 2019 | 3571 | 0.100 |
Why?
|
Immobilized Proteins | 1 | 2011 | 24 | 0.100 |
Why?
|
Thymus Gland | 1 | 2016 | 1241 | 0.100 |
Why?
|
Drug Carriers | 1 | 2016 | 706 | 0.100 |
Why?
|
Aptamers, Peptide | 1 | 2011 | 28 | 0.100 |
Why?
|
Phototherapy | 1 | 2015 | 368 | 0.100 |
Why?
|
Pneumonia | 1 | 2023 | 2140 | 0.100 |
Why?
|
Hyperthermia, Induced | 1 | 2015 | 416 | 0.090 |
Why?
|
Vaccines | 1 | 2019 | 836 | 0.090 |
Why?
|
Molecular Probes | 1 | 2012 | 310 | 0.090 |
Why?
|
Lymph Nodes | 2 | 2019 | 3469 | 0.080 |
Why?
|
Sulfonic Acids | 2 | 2019 | 102 | 0.080 |
Why?
|
Crystallization | 1 | 2010 | 533 | 0.080 |
Why?
|
Quaternary Ammonium Compounds | 2 | 2019 | 202 | 0.080 |
Why?
|
Image Enhancement | 1 | 2019 | 2882 | 0.080 |
Why?
|
Humans | 24 | 2023 | 760437 | 0.080 |
Why?
|
Biological Assay | 1 | 2011 | 626 | 0.080 |
Why?
|
Ligands | 1 | 2015 | 3270 | 0.080 |
Why?
|
Molecular Imaging | 1 | 2015 | 814 | 0.080 |
Why?
|
Protein Binding | 3 | 2015 | 9340 | 0.070 |
Why?
|
Palladium | 1 | 2008 | 67 | 0.070 |
Why?
|
Molecular Biology | 1 | 2011 | 580 | 0.070 |
Why?
|
Influenza, Human | 1 | 2018 | 1517 | 0.070 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2014 | 803 | 0.070 |
Why?
|
Pyrimidines | 1 | 2019 | 3024 | 0.070 |
Why?
|
Streptavidin | 3 | 2014 | 82 | 0.070 |
Why?
|
Immunotherapy | 1 | 2022 | 4649 | 0.070 |
Why?
|
Pulmonary Alveoli | 1 | 2009 | 650 | 0.070 |
Why?
|
Limit of Detection | 2 | 2017 | 272 | 0.060 |
Why?
|
Chlorides | 1 | 2008 | 665 | 0.060 |
Why?
|
Bronchi | 1 | 2009 | 845 | 0.060 |
Why?
|
Microscopy, Electron, Transmission | 2 | 2017 | 696 | 0.060 |
Why?
|
Allergens | 2 | 2023 | 1410 | 0.060 |
Why?
|
Receptors, Colony-Stimulating Factor | 1 | 2023 | 50 | 0.060 |
Why?
|
Complement C1q | 1 | 2023 | 94 | 0.050 |
Why?
|
Biological Availability | 1 | 2023 | 390 | 0.050 |
Why?
|
Antibodies, Monoclonal | 1 | 2019 | 9176 | 0.050 |
Why?
|
Platinum | 1 | 2023 | 220 | 0.050 |
Why?
|
Poloxamer | 1 | 2022 | 56 | 0.050 |
Why?
|
Molecular Conformation | 2 | 2015 | 545 | 0.050 |
Why?
|
Catalysis | 2 | 2016 | 774 | 0.050 |
Why?
|
Carboplatin | 1 | 2023 | 793 | 0.040 |
Why?
|
Male | 6 | 2019 | 360035 | 0.040 |
Why?
|
Rhodamines | 2 | 2011 | 178 | 0.040 |
Why?
|
High-Throughput Screening Assays | 2 | 2019 | 934 | 0.040 |
Why?
|
Surface-Active Agents | 1 | 2020 | 149 | 0.040 |
Why?
|
Light | 2 | 2016 | 1351 | 0.040 |
Why?
|
Microscopy, Fluorescence | 2 | 2019 | 2647 | 0.040 |
Why?
|
Ions | 1 | 2019 | 256 | 0.040 |
Why?
|
Influenza in Birds | 1 | 2018 | 76 | 0.040 |
Why?
|
Biotin | 2 | 2009 | 254 | 0.040 |
Why?
|
Aniline Compounds | 2 | 2017 | 1069 | 0.040 |
Why?
|
Delayed-Action Preparations | 1 | 2022 | 961 | 0.040 |
Why?
|
Birds | 1 | 2018 | 168 | 0.040 |
Why?
|
Influenza A Virus, H5N1 Subtype | 1 | 2018 | 113 | 0.040 |
Why?
|
Breast Neoplasms | 2 | 2015 | 20985 | 0.040 |
Why?
|
Ovalbumin | 1 | 2019 | 672 | 0.040 |
Why?
|
Cisplatin | 1 | 2023 | 1647 | 0.040 |
Why?
|
Rivers | 1 | 2017 | 64 | 0.040 |
Why?
|
Solubility | 1 | 2019 | 1091 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2018 | 9003 | 0.030 |
Why?
|
Methylene Blue | 1 | 2016 | 155 | 0.030 |
Why?
|
Stem Cells | 1 | 2009 | 3522 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2023 | 1624 | 0.030 |
Why?
|
Antigen-Presenting Cells | 1 | 2019 | 964 | 0.030 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 2015 | 201 | 0.030 |
Why?
|
Spectrophotometry, Infrared | 1 | 2015 | 117 | 0.030 |
Why?
|
Algorithms | 1 | 2015 | 14002 | 0.030 |
Why?
|
Oxazines | 1 | 2016 | 348 | 0.030 |
Why?
|
Static Electricity | 1 | 2015 | 261 | 0.030 |
Why?
|
Cotinine | 1 | 2015 | 203 | 0.030 |
Why?
|
Mice, Inbred Strains | 1 | 2016 | 1759 | 0.030 |
Why?
|
Rats | 2 | 2022 | 23712 | 0.030 |
Why?
|
Prostatic Neoplasms | 1 | 2017 | 11095 | 0.030 |
Why?
|
Photosensitizing Agents | 1 | 2018 | 623 | 0.030 |
Why?
|
Rats, Wistar | 1 | 2017 | 1844 | 0.030 |
Why?
|
Biotinylation | 1 | 2014 | 184 | 0.030 |
Why?
|
Iron | 1 | 2022 | 1787 | 0.030 |
Why?
|
Amines | 1 | 2015 | 281 | 0.030 |
Why?
|
Water Pollutants, Chemical | 1 | 2017 | 356 | 0.030 |
Why?
|
Immunoglobulin E | 1 | 2019 | 1494 | 0.030 |
Why?
|
Serum Albumin, Bovine | 1 | 2014 | 322 | 0.030 |
Why?
|
Dextrans | 1 | 2015 | 573 | 0.030 |
Why?
|
Spectrometry, Fluorescence | 1 | 2015 | 685 | 0.030 |
Why?
|
Amino Acids | 1 | 2019 | 1717 | 0.030 |
Why?
|
Photons | 1 | 2016 | 585 | 0.030 |
Why?
|
Scattering, Radiation | 1 | 2014 | 490 | 0.030 |
Why?
|
Molecular Structure | 1 | 2017 | 1875 | 0.030 |
Why?
|
Antibodies, Immobilized | 1 | 2012 | 23 | 0.030 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2014 | 944 | 0.030 |
Why?
|
Dendritic Cells | 1 | 2023 | 2725 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 2017 | 1228 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2022 | 8163 | 0.020 |
Why?
|
Immunoassay | 1 | 2015 | 746 | 0.020 |
Why?
|
Endocytosis | 1 | 2015 | 958 | 0.020 |
Why?
|
Optical Phenomena | 1 | 2010 | 106 | 0.020 |
Why?
|
Fluorenes | 1 | 2011 | 157 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2019 | 18216 | 0.020 |
Why?
|
Metals | 1 | 2014 | 716 | 0.020 |
Why?
|
Color | 1 | 2010 | 299 | 0.020 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 2009 | 222 | 0.020 |
Why?
|
Aspartic Acid | 1 | 2011 | 576 | 0.020 |
Why?
|
Thrombin | 1 | 2011 | 590 | 0.020 |
Why?
|
RNA Helicases | 1 | 2009 | 144 | 0.020 |
Why?
|
Naphthalenes | 1 | 2009 | 198 | 0.020 |
Why?
|
Aptamers, Nucleotide | 1 | 2009 | 165 | 0.020 |
Why?
|
Fluorescence | 1 | 2010 | 756 | 0.020 |
Why?
|
Doxorubicin | 1 | 2015 | 2215 | 0.020 |
Why?
|
Cattle | 1 | 2014 | 3849 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2023 | 14397 | 0.020 |
Why?
|
Kinetics | 1 | 2015 | 6377 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6765 | 0.020 |
Why?
|
Glutathione Transferase | 1 | 2009 | 565 | 0.020 |
Why?
|
Macromolecular Substances | 1 | 2010 | 1435 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9533 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2019 | 22121 | 0.020 |
Why?
|
Swine | 1 | 2016 | 5915 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2015 | 20078 | 0.020 |
Why?
|
Materials Testing | 1 | 2010 | 864 | 0.020 |
Why?
|
Spectrum Analysis | 1 | 2008 | 451 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2019 | 11070 | 0.020 |
Why?
|
Cell Membrane | 1 | 2015 | 3685 | 0.020 |
Why?
|
Female | 6 | 2022 | 391875 | 0.020 |
Why?
|
Endoscopy | 1 | 2015 | 1849 | 0.020 |
Why?
|
Models, Molecular | 1 | 2015 | 5427 | 0.020 |
Why?
|
Cell Survival | 1 | 2015 | 5790 | 0.010 |
Why?
|
Hot Temperature | 1 | 2010 | 1440 | 0.010 |
Why?
|
Models, Biological | 1 | 2019 | 9462 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2014 | 4063 | 0.010 |
Why?
|
Quality of Life | 1 | 2022 | 13338 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2010 | 13445 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2009 | 5865 | 0.010 |
Why?
|
Signal Transduction | 1 | 2019 | 23397 | 0.010 |
Why?
|
Mass Screening | 1 | 2012 | 5424 | 0.010 |
Why?
|
Child, Preschool | 1 | 2018 | 42209 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2009 | 18955 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 64591 | 0.010 |
Why?
|
Young Adult | 1 | 2018 | 59068 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2018 | 36362 | 0.010 |
Why?
|
Child | 1 | 2018 | 80086 | 0.010 |
Why?
|
Adolescent | 1 | 2018 | 88196 | 0.010 |
Why?
|
Adult | 1 | 2018 | 220781 | 0.000 |
Why?
|
Concepts
(226)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(10)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_